Medicare Part D coverage of GLP-1s could raise costs by $48B
(By: Alexandra Murphy for Becker’s Hospital Review) Medicare coverage of obesity medications could drive a substantial rise in healthcare spending,
Read More
Part D/Prescription Drugs
Stand-Alone Drug Plans Cover a Larger Share of Medicare Part D Enrollees Living in the Most Rural Areas Than Medicare Advantage Plans
(By Juliette Cubanski, Tricia Neuman, and Anthony Damico for The Kaiser Family Foundation Published: Apr 23, 2025) The growing role
Read MoreAttorneys general to Congress: Ban PBMs from owning pharmacies
By: Alexandra Murphy for Becker’s Hospital Review) A coalition of 39 state attorneys general called on Congress to pass legislation
Read MoreThe Effect of Delaying the Selection of Small Molecule Drugs for Medicare Drug Price Negotiation
(By Juliette Cubanski and Tricia Neuman for The Kaiser Family Foundation Published: Apr 16, 2025) President Trump has just signed
Read MoreYou’re probably taking over-the-counter painkillers incorrectly
(By Andee Tagle for NPR) When hit with a headache or fever, people often reach for over-the-counter painkillers like acetaminophen
Read MoreTrump signs executive action to lower drug prices
(By Sydney Lupkin for NPR) President Trump signed an executive action Tuesday intended to lower prescription drug prices for Americans.
Read MoreFewer than One in Five Medicare Enrollees Received Medication to Treat Their Opioid Use Disorder
(Source – oig.hhs.gov) In 2023, about 53,000 Medicare Part D enrollees experienced an opioid-related overdose. This is the number of
Read MoreMedicare will not cover GLP-1s for weight loss: 3 notes
(By: Erica Carbajal for Becker’s Hospital Review) CMS said April 4 it will not move forward with a Biden-era proposal
Read MoreWho is enrolling in Medicare Advantage?
The creation of Medicare Advantage health plans was part of the 1997 Balanced Budget Act. Medicare Advantage grew from almost
Read MoreOperationalizing the scope of the Medicare drug negotiations
The Inflation Reduction Act of 2022 allowed Medicare to directly negotiate the prices of certain high-expenditure, single-source drugs without generic
Read More